Aptinyx Annual Revenue, Number of Employees, Growth and Funding
Estimated Revenue & Financials
- Aptinyx's estimated annual revenue is currently $6.7M per year.
- Aptinyx received $70.0M in venture funding in December 2017.
- Aptinyx's estimated revenue per employee is $112,000
- Aptinyx's total funding is $237.4M.
- Aptinyx has 60 Employees.
- Aptinyx grew their employee count by -14% last year.
- Aptinyx currently has 1 job openings.
|Sarah Torri||Senior Director, Clinical Development|
|Tony Smolcich||Senior Director Information Technology at Aptinyx|
|Katie Hardek||Director, Human Resources|
|Amber Johnson||Associate Director of Finance|
|Nick Smith||Director, Corporate Development|
|Torsten Meldgaard||Chief Medical Officer at Aptinyx|
|David Houck||Chief Development Officer|
|Andy Kidd||Chief Operating Officer|
|Ashish Khanna||Chief Financial Officer and Chief Business Officer|
What Is Aptinyx?
Welcome to our company page and thank you for your interest in Aptinyx Inc. Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. At Aptinyx, we remain committed and responsive to our employees. We offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. If you are interested in learning more, please visit our website at www.aptinyx.com.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Heidolph North ...||$7.9M||55||17%||N/A|
EVANSTON, Ill., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing ...
Aptinyx Inc. (NASDAQ:APTX) Q2 2019 Results Earnings Conference Call August 12, 2019 8:00 AM ET. Company Participants. Nick Smith ...
On August 12, 2019, Aptinyx Inc., issued a press release announcing its financial results for the quarter ended June 30, 2019. A copy of the ...
|2016-05-10||$65.0M||A||New Leaf Venture Partners||Article|
|2017-12-19||$70.0M||B||Bain Capital Life Sciences||Article|
Aptinyx Executive Hires
|2017-12-08||Andy Kidd||Chief commercial officer||Article|
|2018-02-14||Ashish Khanna||Chief Financial Officer and Chief Business Officer||Article|
|2018-05-04||David Houck||Chief Development Officer||Article|